US drug approvals
6 approvals with a product on the US market
- Emrosi NDA219015 · approved 1 Nov 2024
- Zilxi NDA213690 · approved 28 May 2020
- Amzeeq NDA212379 · approved 18 Oct 2019
- Qbrexza NDA210361 · approved 28 Jun 2018
- Exelderm NDA018737 · approved 28 Feb 1989
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.